CD4 and cancer: Remarkably, we observed a significant positive correlation between R3HDM1 expression and B cells, CD4+T cells, CD8+T cells, and Treg cells in nearly all cancer types, hinting at R3HDM1’s partial participation in immune evasion or immune tolerance, pivotal in immune-tumor interplay, notably immune escape.